Spastic paraparesis

Common Name(s)

Spastic paraparesis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Spastic paraparesis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Spastic paraparesis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Spastic paraparesis" returned 161 free, full-text research articles on human participants. First 3 results:

An epidemic of spastic paraparesis of unknown aetiology in Northern Mozambique.
 

Author(s): Cátia Luciana Abdulfattáhe Taibo, Julie Cliff, Hans Rosling, Casey Daniel Hall, Meeyoung Mattie Park, Joseph Asamoah Frimpong

Journal:

 

This case study is based on a real-life outbreak investigation undertaken in Mozambique in 1981. This case study describes and promotes one particular approach to unknown disease outbreak investigation. Investigational procedures, however, may vary depending on location and outbreak. ...

Last Updated: 19 Jul 2017

Go To URL
Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis.
 

Author(s): Satoshi Nozuma, Eiji Matsuura, Daisuke Kodama, Yuichi Tashiro, Toshio Matsuzaki, Ryuji Kubota, Shuji Izumo, Hiroshi Takashima

Journal:

 

Although human T-lymphotropic virus type 1 (HTLV-1) infection is a prerequisite for the development of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), specific provirus mutations in HAM/TSP have not yet been reported. In this study, we examined whether HAM/TSP ...

Last Updated: 19 Apr 2017

Go To URL
Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.
 

Author(s): Massanobu Takatani, Myuki Esashika Crispim, Nelson Fraiji, Mariane Martins Araujo Stefani, Dagmar Kiesslich

Journal:

 

Clinical and laboratory parameters including blood and cerebrospinal fluid (CSF) neopterin were investigated in human-T-lymphotropic-virus-type-I associated-myelopathy/tropical-spastic-paraparesis-HAM/TSP and in HTLV-I carriers. HAM/TSP (n = 11, 2 males/9 females, median age = 48 ...

Last Updated: 5 Apr 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Spastic paraparesis" returned 14 free, full-text review articles on human participants. First 3 results:

[Progressive spastic paraparesis and static syringomyelia: Silver syndrome/SPG17].
 

Author(s): Miguel Lafuente-Hidalgo, José L Peña-Segura, Rosana Ranz-Angulo, Alberto García-Oguiza, Raquel Pérez-Delgado, Silvia Izquierdo-Álvarez, Javier López-Pisón

Journal: Rev Neurol. 2015 Aug;61(4):188-91.

 

Last Updated: 24 Jul 2015

Go To URL
[Tropical spastic paraparesis: a report of a new case in Spain].
 

Author(s): Luciana Midaglia, Antonio Pato-Pato, Iria Rodriguez-Constenla, Eloísa Santos-Armentia, Iciar Cimas-Hernando, María Lopez-Fernandez, Delicias Munoz-Garcia, Candelas Valeiras-Munoz, José R Lorenzo-Gonzalez

Journal: Rev Neurol. 2014 Jun;58(12):573-5.

 

Last Updated: 11 Jun 2014

Go To URL
HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
 

Author(s): Tatsufumi Nakamura

Journal: Folia Neuropathol. 2009 ;47(2):182-94.

 

Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic progressive myelopathy characterized by bilateral pyramidal tract involvement with sphincteric disturbances. The primary neuropathological feature of HAM/TSP is chronic ...

Last Updated: 20 Jul 2009

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection
 

Status: Not yet recruiting

Condition Summary: HTLV-I Infections; Tropical Spastic Paraparesis

 

Last Updated: 11 Jan 2016

Go to URL
Evaluation of Patients With HAM/TSP
 

Status: Recruiting

Condition Summary: HTLV-I Infection; Tropical Spastic Paraparesis

 

Last Updated: 18 Oct 2017

Go to URL
Raltegravir for HAM/TSP
 

Status: Recruiting

Condition Summary: HTLV-I Infection

 

Last Updated: 3 Nov 2017

Go to URL